{"name":"Torque Therapeutics","slug":"torque","ticker":"Private","exchange":"Private","domain":"torquetx.com","description":"Torque Therapeutics is a private biotechnology company focused on developing innovative immunotherapies for the treatment of cancer. The company's pipeline includes several promising cell therapy products. With a strong focus on immuno-oncology, Torque Therapeutics aims to revolutionize cancer treatment. As a private company, limited information is publicly available, but the company has shown significant progress in recent years.","hq":"Cambridge, MA","founded":0,"employees":"","ceo":"Deborah Bhatt","sector":"Immuno-Oncology / Cell Therapy","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private (~$250M last valuation)","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Lead Candidate patent cliff ($100M at risk)","drug":"Lead Candidate","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"regulatory","headline":"Torque Therapeutics Receives FDA Orphan Drug Designation for Lead Candidate","summary":"Torque Therapeutics announced that its lead candidate has received FDA Orphan Drug Designation for the treatment of a specific type of cancer.","drugName":"Lead Candidate","sentiment":"positive"},{"date":"2023-06-01","type":"deal","headline":"Torque Therapeutics Secures $50M Series C Financing","summary":"Torque Therapeutics announced the completion of a $50 million Series C financing round, led by new investor, a leading biotech-focused venture capital firm.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOcnFhRmg1eHd2Y3dNWVB4aU1ZR1BIczl4ajFnTDRlVWQwbUFTSmRtMXhfVzRZeXBXUmdZZVZmaXZtQmRaR0w5dE1TWlJHNDlTeEt2ZUl1aTkxaG9BcEJsNGJTZC10a1dvMzFNZnlJYzBxS25VVG9zSVU3cU1Hb0pqTjh6Zmx0Zy1KVS0yUHhnU1R4S0JibXRmMmhDcWZLRWppNEpHaVRiX1VQek5xbU5mQnBmTTAxcjFPTmNBZTZPQQ?oc=5","date":"2026-01-22","type":"pipeline","source":"The South First","summary":"Tamil Nadu flags 24 substandard cough syrups—including Sresan's—months after child deaths - The South First","headline":"Tamil Nadu flags 24 substandard cough syrups—including Sresan's—months after child deaths","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-22","type":"pipeline","source":"Medical Dialogues","summary":"CDSCO Flags 74 Drugs, Devices Samples as NSQ in December: Zerodol-SP, Defcort, Telmisartan, Amikacin... - Medical Dialogues","headline":"CDSCO Flags 74 Drugs, Devices Samples as NSQ in December: Zerodol-SP, Defcort, Telmisartan, Amikacin...","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-07-24","type":"trial","source":"Medical Dialogues","summary":"30 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert - Medical Dialogues","headline":"30 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1oT2VvMW9QXzJ5bXIxYlRVaE5Zdy03MUJiUzQwUWpqMTBqMkh1clpkVFpTOUtEWEc0akQtZVg5WUV6NFhKTHdjdC1aRDI1bFlnMHFlMWczWlRPRFlVazZvdFBTRXp1eTB5emR3?oc=5","date":"2024-03-20","type":"deal","source":"Pharmabiz.com","summary":"Collaboration between private & public sectors to drive healthcare innovation & accessibility: Expert - Pharmabiz.com","headline":"Collaboration between private & public sectors to drive healthcare innovation & accessibility: Expert","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-10-18","type":"pipeline","source":"Medical Dialogues","summary":"59 Drug Samples Including Cadila pharma Aciloc 150 Fail To Qualify CDSCO Test - Medical Dialogues","headline":"59 Drug Samples Including Cadila pharma Aciloc 150 Fail To Qualify CDSCO Test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQbDFUTEJacFk2RU16UEduOWRXQTRxMmgzQjZ1bEY3dWptTXpmT0czU29mbmdCVG5WNWZ4YmdfcTFZYkMxVFE0c1NIWHdBVXNXeWV6eTJBT1lKR2hLaHV5U1I3ZUFnVGFpVlM1QnhKMVBtcVBDNXFrdDIzSnl4b3Izdm930gGGAUFVX3lxTE9sQWhzNFE4ZkI5ZHlfS1d5U042Uy1wN2ZJc0JELUpZTzB1UnJ2UTd3SnJIRUZlWXNtNUNQQXJsQW5hZjM5Y21nTWgxRjRWd1hhblhQY0dOaFNSWWhyeENycUk5eUtrUkRjRmNmdmpqUEFCT2hHeGVzRXJQR09rNDhBWWRMZVhB?oc=5","date":"2021-12-12","type":"pipeline","source":"Tribune India","summary":"I-T Raid at Torque Pharma, JW Marriott Hotel: Rs 3.5 crore, 4-kg jewellery seized - Tribune India","headline":"I-T Raid at Torque Pharma, JW Marriott Hotel: Rs 3.5 crore, 4-kg jewellery seized","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1MM2FLVVJPWWFjVGpaWkdqajNfS0tkbXVvQmJBNUlOR1lLSHJNdUdHR1NvVDNvdWdTdHZBTEhIQlNPemY2N3YtelFKZFlTQS1NVXVXOFpvbmlIQ3hKSDRjcU1xNGowRzVqYTU5ajdyZXpuQUxCMGN1SWllQXhZbm8?oc=5","date":"2020-12-15","type":"pipeline","source":"Allied Market Research","summary":"Ear Infection Treatment Market Statistics | Forecast - 2032 - Allied Market Research","headline":"Ear Infection Treatment Market Statistics | Forecast - 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQM0hXT2hQSXNaSjJ3RGwwdWxjakxvbWVZZUhvZDg0RTFKVWFJbUlmRVNRelhtR0RUeXhDUEpYZlhUbm55d21rZ3gxV0pHWlZRLUczVThKR2pOcDlhMGs5bEJjM3k2V0lpcnFTbi02VzdHNjZ6QWgzRl9NUmI2VFFQUVE4ME5CSXY4eHMwRVowd0tqM2xoZDFBaG4tcnlLczNQTXVNTjhPQ28?oc=5","date":"2018-09-14","type":"pipeline","source":"The Economic Times","summary":"TORQUE PHARMACEUTICALS PRIVATE LIMITED - The Economic Times","headline":"TORQUE PHARMACEUTICALS PRIVATE LIMITED","sentiment":"neutral"}],"patents":[{"drugName":"Lead Candidate","drugSlug":"generic-name-not-available","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Bristol Myers Squibb","Merck & Co.","Gilead Sciences"],"therapeuticFocus":["Immuno-Oncology","Cell Therapy"],"financials":null,"yahoo":null}